Jacob is a Digital News Officer at Cancer Research UK. He studied biochemistry at the University of Exeter and subsequently completed a Master’s in science communication at Imperial College London. He joined the digital news team in March 2022, writing for the news site and contributing to our podcast, That Cancer Conversation.
Cancer Research UK, in partnership with tech company Stitch, are going live with an app for patients to use whilst participating in a clinical trial.
Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer
Researchers in Southampton have found that a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs
Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types
Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.
A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that’s quickly establishing itself as the best of the best.
NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective
A long-term study funded by Cancer Research UK has revealed how air pollution can cause lung cancer in people who have never smoked.
We hear from four of our Campaigns Ambassadors in Scotland about what they want to see in a new, comprehensive 10-Year Cancer Plan
If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that.